Response of prostate cancer to addition of dutasteride after progression on abiraterone

Detalles Bibliográficos
Autores principales: Lian, Jian-Po, Gao, Yuan-Yuan, Tang, Jing-Jie, Chen, Xi, Liu, Ying, Wu, Deng-Long, Li, Zhen-Fei, Huang, Sheng-Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991817/
https://www.ncbi.nlm.nih.gov/pubmed/32896838
http://dx.doi.org/10.4103/aja.aja_45_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991817/
https://www.ncbi.nlm.nih.gov/pubmed/32896838
http://dx.doi.org/10.4103/aja.aja_45_20

Ejemplares similares